Takeda

Expanding leadership of Takeda's R&D therapeutic area focus to include Rare Diseases in addition to GI, Neuroscience and Oncology, and supporting our broader healthcare aspirations in Vaccines and Plasma-Derived Therapies. We continue to emphasize patient-centric R&D founded on innovative translational science, leveraging a range of therapeutic modalities and an extensive network of external partnerships. Fostering a values-based, agile, and dynamic organizational culture that emphasizes people and operational effectiveness. Having successfully advanced multiple approvals in our core therapeutic areas and transformed our R&D organization over the past several years, we are currently focused on delivering a pipeline of next generation, innovative, life altering therapies for patients.

As Takeda’s Chief Medical Officer, I lead the Global Medical Team in delivering transformative treatments to enable patients to live fulfilling lives beyond their diagnosis. We translate the scientific potential of our medicines into clinical practice through rigorous clinical research and evidence communication to advance standards of care, and support the clinical and safety profiles of our entire medicines portfolio.